|
Crosswalk of Changes to CO-OP Monthly Reporting Guidance and Template |
|
|
30-Mar-15 |
|
|
|
|
|
# |
Form |
Change |
Current Location |
Reason |
1 |
Monthly Reporting Guidance |
Date changed to May 15, 2015 |
p. 1 |
To reflect the new approval date. |
2 |
Monthly Reporting Guidance |
Item 13: Total written premiums (gross) and considerations |
p. 2 |
clarification of which premiums to be reported. |
3 |
Monthly Reporting Guidance |
Item 17: deleted "total administrative expenses incurred" |
p. 2 and p. 5 |
deleted as it is collected in item 27. |
4 |
Monthly Reporting Guidance |
Item 19: Added "Investment Income Receivables" |
p. 2 and p. 5 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
5 |
Monthly Reporting Guidance |
Item 20: Added "Healthcare Receivables" |
p. 2 and p. 5 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
6 |
Monthly Reporting Guidance |
Item 21: Added "PDR" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
7 |
Monthly Reporting Guidance |
Item 22: Added "Capital and Surplus" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
8 |
Monthly Reporting Guidance |
Item 23: Added "Federal Reinsurance Premiums" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
9 |
Monthly Reporting Guidance |
Item 24: Added "Commercial Federal Reinsurance Premiums" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
10 |
Monthly Reporting Guidance |
Item 25: Added "Federal Reinsurance Recoveries" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
11 |
Monthly Reporting Guidance |
Item 26: Added "Commercial Reinsurance Recoveries" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
12 |
Monthly Reporting Guidance |
Item 27: Added "Total G&A Expenses" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
13 |
Monthly Reporting Guidance |
Item 28: Added "Claims Adjustment Expenses" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
14 |
Monthly Reporting Guidance |
Item 29: Added "Net Investment Income (Loss)" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
15 |
Monthly Reporting Guidance |
Item 30: Added "Other Income (Loss)" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
16 |
Monthly Reporting Guidance |
Item 31: Added "Net Income (Loss)" |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
17 |
Monthly Reporting Guidance |
Item 32: Moved "DOI Financial Reports" to be Item 32. |
p. 2 and p. 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
18 |
Monthly Reporting Template |
Item 13: Total written premiums (gross) and considerations |
Row AC, Line 6 |
clarification of which premiums to be reported. |
19 |
Monthly Reporting Template |
Item 17: deleted "total administrative expenses incurred" |
Row AE, Line 6 |
deleted as it is collected in item 27. |
20 |
Monthly Reporting Template |
Item 19: Added "Investment Income Receivables" |
Row AI, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
21 |
Monthly Reporting Template |
Item 20: Added "Healthcare Receivables" |
Row AJ, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
22 |
Monthly Reporting Template |
Item 21: Added "PDR" |
Row AK, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
23 |
Monthly Reporting Template |
Item 22: Added "Capital and Surplus" |
Row AL, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
24 |
Monthly Reporting Template |
Item 23: Added "Federal Reinsurance Premiums" |
Row AM, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
25 |
Monthly Reporting Template |
Item 24: Added "Commercial Federal Reinsurance Premiums" |
Row AN, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
26 |
Monthly Reporting Template |
Item 25: Added "Federal Reinsurance Recoveries" |
Row AO, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
27 |
Monthly Reporting Template |
Item 26: Added "Commercial Reinsurance Recoveries" |
Row AP, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
28 |
Monthly Reporting Template |
Item 27: Added "Total G&A Expenses" |
Row AQ, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
29 |
Monthly Reporting Template |
Item 28: Added "Claims Adjustment Expenses" |
Row AR, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
30 |
Monthly Reporting Template |
Item 29: Added "Net Investment Income (Loss)" |
Row AS, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
31 |
Monthly Reporting Template |
Item 30: Added "Other Income (Loss)" |
Row AT, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
32 |
Monthly Reporting Template |
Item 31: Added "Net Income (Loss)" |
Row AU, Line 6 |
Added because this is a data element used to assess risk using the Risk Assessment Tool. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the fullest extent of the law. |